Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Influenza A Virus Matrix Protein 1 Produits

(Influenza A Virus Matrix Protein 1 (M1))

antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.

Catégories Influenza A Virus Matrix Protein 1 en vedette

Influenza A Virus Matrix Protein 1 Anticorps

High quality antibodies with extensive validation data.

Influenza A Virus Matrix Protein 1 Protéines

Proteins for various applications incl. WB, ELISA, IF etc.

Influenza A Virus Matrix Protein 1 recommandé Anticorps

Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity Influenza A Virus
Application ELISA
Validations
  • (1)
N° du produit ABIN5707180
Quantité 0.1 mg
Fiche technique Fiche technique
Reactivity Influenza A Virus
Application ELISA
Validations
  • (1)
N° du produit ABIN5707179
Quantité 1 mL
Fiche technique Fiche technique
Reactivity Influenza A Virus
Application WB, ELISA, IHC, FM
Validations
N° du produit ABIN7478355
Quantité 1 mL
Fiche technique Fiche technique

Influenza A Virus Matrix Protein 1 recommandé Protéines

Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity Influenza A Virus H5N1
Source Escherichia coli (E. coli)
Validations
N° du produit ABIN1604957
Quantité 100 μg
Fiche technique Fiche technique
Reactivity Influenza A Virus H1N1
Source Escherichia coli (E. coli)
Validations
N° du produit ABIN1605091
Quantité 100 μg
Fiche technique Fiche technique
Reactivity Influenza A Virus H3N2
Source Escherichia coli (E. coli)
Validations
N° du produit ABIN1605188
Quantité 100 μg
Fiche technique Fiche technique

Dernières publications sur nos produits Influenza A Virus Matrix Protein 1

Deo, Kato, Park: "Chimeric virus-like particles made using GAG and M1 capsid proteins providing dual drug delivery and vaccination platform." dans: Molecular pharmaceutics, Vol. 12, Issue 3, pp. 839-45, (2015) (PubMed).

Das, Watanabe, Hatta, Noda, Neumann, Ozawa, Kawaoka: "The highly conserved arginine residues at positions 76 through 78 of influenza A virus matrix protein M1 play an important role in viral replication by affecting the intracellular localization of M1." dans: Journal of virology, Vol. 86, Issue 3, pp. 1522-30, (2012) (PubMed).

Doucet, Forget, Grange, Rouxel, Arbour, von Messling, Lapointe: "Endogenously expressed matrix protein M1 and nucleoprotein of influenza A are efficiently presented by class I and class II major histocompatibility complexes." dans: The Journal of general virology, Vol. 92, Issue Pt 5, pp. 1162-71, (2011) (PubMed).

Liu, Massare, Barnard, Kort, Nathan, Wang, Smith: "Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV." dans: Vaccine, Vol. 29, Issue 38, pp. 6606-13, (2011) (PubMed).

Viemann, Schmolke, Lueken, Boergeling, Friesenhagen, Wittkowski, Ludwig, Roth: "H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 186, Issue 1, pp. 164-73, (2010) (PubMed).

Wang, Harmon, Jin, Francis, Christopher-Hennings, Nelson, Montelaro, Li: "The lack of an inherent membrane targeting signal is responsible for the failure of the matrix (M1) protein of influenza A virus to bud into virus-like particles." dans: Journal of virology, Vol. 84, Issue 9, pp. 4673-81, (2010) (PubMed).

Luig, Köther, Dudek, Gaestel, Hiscott, Wixler, Ludwig: "MAP kinase-activated protein kinases 2 and 3 are required for influenza A virus propagation and act via inhibition of PKR." dans: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 24, Issue 10, pp. 4068-77, (2010) (PubMed).

Eierhoff, Hrincius, Rescher, Ludwig, Ehrhardt: "The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells." dans: PLoS pathogens, Vol. 6, Issue 9, pp. e1001099, (2010) (PubMed).

Kang, Yoo, Lipatov, Song, Davis, Quan, Chen, Donis, Compans: "Induction of long-term protective immune responses by influenza H5N1 virus-like particles." dans: PLoS ONE, Vol. 4, Issue 3, pp. e4667, (2009) (PubMed).

Kirkeby, Martel, Aasted: "Infection with human H1N1 influenza virus affects the expression of sialic acids of metaplastic mucous cells in the ferret airways." dans: Virus research, Vol. 144, Issue 1-2, pp. 225-32, (2009) (PubMed).

Vous êtes ici:
Support technique